Top 20 Female Healthcare Leaders [2026]

What happens when vision, science, and leadership intersect in the hands of women? The global healthcare landscape provides a powerful answer. From biotechnology to public health, women leaders are redefining the future of medicine by blending innovation with empathy. Their impact goes far beyond boardrooms and laboratories—they are shaping access to care, advancing medical breakthroughs, and ensuring that equity becomes a non-negotiable standard in healthcare delivery.

In a world where healthcare challenges grow more complex—from pandemics to chronic diseases—these leaders are not only solving urgent problems but also setting the stage for sustainable, data-driven progress. They embody what can only be described as digital defined leadership: the ability to leverage technology, analytics, and global collaboration to create healthcare systems that are more efficient, inclusive, and resilient.

This list of 20 female healthcare leaders highlights pioneers who are pushing the boundaries of science and policy. Each of them stands as proof that leadership in healthcare is not just about business growth—it’s about improving lives. Their journeys are not only inspiring stories of personal achievement but also roadmaps for how the industry can thrive in the years ahead.

 

Related: How Can Healthcare Leaders Use AI?

 

Top 20 Female Healthcare Leaders [2026]

Leader	Current Role	Organization	Country	Key Focus / Contribution
Emma Walmsley	CEO	GSK	UK	First woman to lead a major pharma; focus on vaccines & biopharma growth
Belén Garijo	Chair & CEO	Merck KGaA	Germany	First female CEO of Merck; advancing biotech, digital health, & sustainability
Gail K. Boudreaux	President & CEO	Elevance Health	USA	Transforming health insurance with tech integration & value-based care
Sarah M. London	CEO	Centene Corporation	USA	Youngest female CEO in US healthcare; driving data-driven Medicaid/Medicare services
Reshma Kewalramani	CEO & President	Vertex Pharmaceuticals	USA	Leading biotech innovation in cystic fibrosis, gene editing & rare diseases
Teresa Graham	CEO	Roche Pharmaceuticals	Switzerland	Driving oncology, immunology, and personalized healthcare strategy
Judy Faulkner	Founder & CEO	Epic Systems	USA	Pioneer of EHR systems; built Epic into world’s leading health IT firm
Prof. Özlem Türeci	Co-founder & CMO	BioNTech	Germany	Co-developed first mRNA COVID-19 vaccine; leading cancer immunotherapy
Seema Verma	EVP & GM	Oracle Health & Life Sciences	USA	Former CMS Administrator; advancing digital health & interoperability
Angela Hwang	CEO-Partner	Flagship Pioneering / Metaphore Biotech	USA	Former Pfizer CCO; led COVID-19 vaccine rollout, now scaling biotech startups
Dr. Hanan H. Balkhy	Regional Director	WHO Eastern Mediterranean	Regional	Global AMR expert; leading WHO programs in 22 countries
Dr. Hanan Mohamed Al Kuwari	Minister of Public Health	Qatar Gov. & HMC	Qatar	Driving healthcare modernization, digitalization, & pandemic response
Kiran Mazumdar-Shaw	Executive Chairperson	Biocon & Biocon Biologics	India	“Biotech Queen of India”; pioneer of affordable biologics & biosimilars
Ameera Shah	MD	Metropolis Healthcare	India	Built one of India’s largest diagnostics chains; advocate for preventive care
Dr. Preetha Reddy	Executive Vice Chairperson	Apollo Hospitals	India	Shaping Apollo’s strategy, quality, and rural outreach
Dr. Sangita Reddy	Joint MD	Apollo Hospitals	India	Leading digital health, telemedicine, and global policy initiatives
Zhong Huijuan	Chair & CEO	Hansoh Pharmaceutical	China	Built one of China’s biggest pharma firms; focus on oncology & CNS drugs
Julie L. Gerberding	President & CEO	Foundation for the NIH	USA	Former CDC Director; leads global biomedical research partnerships
Nora D. Volkow	Director	NIDA, NIH	USA	Neuroscientist reframing addiction as a brain disease; driving opioid response
Karen S. Lynch	Former CEO	CVS Health; Director, Thermo Fisher	USA	First woman to lead Fortune 5 healthcare giant; expanded primary care & vaccines

 

1. Emma Walmsley – CEO, GSK

Emma Walmsley is the Chief Executive Officer of GSK, one of the world’s leading biopharmaceutical companies, and the first woman to lead a major global pharmaceutical firm. Appointed CEO in 2017, she brought a strong track record in consumer health and strategy, having previously led GSK’s consumer healthcare division. Her leadership has been marked by a clear focus on innovation in pharmaceuticals and vaccines, a sharper organizational structure, and a drive to make GSK more competitive in the rapidly evolving healthcare landscape.

Under her tenure, GSK completed a major corporate restructuring, including the spin-off of its consumer health arm into Haleon, allowing the company to focus on biopharma and vaccines. Walmsley has emphasized the importance of R&D productivity, strengthening the pipeline in oncology, infectious diseases, and immunology. She has also championed diversity and inclusion, becoming a role model for women in leadership in traditionally male-dominated industries. With her business acumen, strategic clarity, and patient-centered vision, Walmsley has positioned GSK as a global player committed to delivering transformative medicines and vaccines.

 

2. Belén Garijo – CEO, Merck KGaA

Belén Garijo is Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany, becoming the first woman to lead the 350-year-old science and technology company. Appointed CEO in May 2021, she oversees a diversified enterprise spanning healthcare, life sciences, and performance materials. Trained as a physician, Garijo began her career in clinical practice before moving into the pharmaceutical industry, where she developed a reputation for operational excellence and transformative leadership.

Prior to becoming CEO, she was CEO of the Healthcare business, where she drove strong growth through oncology, immunology, and fertility treatments. As global CEO, Garijo has accelerated Merck’s innovation agenda, strengthening its biotech pipeline, expanding digital and data-driven healthcare solutions, and positioning the company at the forefront of scientific discovery. She has also prioritized sustainability, digitalization, and global health access, aligning Merck’s strategy with long-term societal needs.

Garijo is widely recognized for her advocacy of gender equity and diversity in leadership, serving as a powerful example for women across industries. Under her guidance, Merck continues to evolve as a future-focused science and technology leader, balancing innovation, sustainability, and financial growth.

 

3. Gail K. Boudreaux – President & CEO, Elevance Health

Gail K. Boudreaux is the President and Chief Executive Officer of Elevance Health, one of the largest health insurance and managed care companies in the United States, serving over 100 million people. She assumed the role in 2017 and has since led the company through a period of transformation, including its rebranding from Anthem to Elevance Health to reflect its broader commitment to whole-person care.

Boudreaux’s career spans more than three decades in the healthcare industry, with senior leadership roles at UnitedHealthcare, Blue Cross Blue Shield, and Aetna. At Elevance, she has focused on integrating technology, data, and value-based care models to improve outcomes and lower costs. Her leadership has emphasized expanding digital health platforms, advancing behavioral health, and addressing social determinants of health.

Recognized as one of the most powerful women in business, Boudreaux has consistently appeared on Fortune’s and Forbes’ lists of top leaders. She is also a strong advocate for diversity, equity, and inclusion within healthcare and corporate leadership. With her strategic vision and patient-centric approach, Boudreaux continues to drive Elevance Health’s mission of improving lives and communities through better health solutions.

 

4. Sarah M. London – CEO, Centene Corporation

Sarah M. London is the Chief Executive Officer of Centene Corporation, a Fortune 25 healthcare enterprise that provides services to nearly 30 million individuals, primarily through government-sponsored programs such as Medicaid and Medicare. She was appointed CEO in 2022, becoming one of the youngest female leaders of a major U.S. healthcare company.

Before becoming CEO, London served as Centene’s Vice Chair, overseeing technology, data analytics, and strategy. Her background includes roles at Optum and leadership in digital health innovation, equipping her with deep expertise in applying data science and technology to improve healthcare delivery. At Centene, she has prioritized operational discipline, simplification, and leveraging advanced analytics to drive quality and efficiency.

London’s leadership is marked by her commitment to transforming healthcare for underserved populations. She has advanced Centene’s efforts in expanding access, investing in behavioral health, and integrating community-based solutions. Her forward-looking approach positions Centene as both a payer and innovator, addressing the growing intersection of healthcare and technology.

Widely recognized as a rising leader in the healthcare industry, London exemplifies the next generation of executives focused on equity, innovation, and sustainability in care delivery.

 

5. Reshma Kewalramani – CEO & President, Vertex Pharmaceuticals

Reshma Kewalramani, M.D., FASN, is the Chief Executive Officer and President of Vertex Pharmaceuticals, a leading biotechnology company headquartered in Boston. She became CEO in 2020, making history as the first woman of Indian origin to lead a major global biotech firm. Trained as a physician and nephrologist, she previously held leadership roles at Amgen before joining Vertex in 2017 as Chief Medical Officer.

At Vertex, Dr. Kewalramani has steered the company to continued dominance in cystic fibrosis treatments, while also diversifying its pipeline into gene-editing therapies, rare diseases, and pain management. Under her leadership, the company has expanded its groundbreaking work with CRISPR-based therapies, including promising advances in sickle cell disease and beta thalassemia.

She is recognized for balancing scientific innovation with patient-centric leadership, ensuring access to transformative therapies for underserved populations. Beyond her corporate role, Kewalramani actively supports STEM education and leadership programs for women and minorities in science. Her vision is rooted in a belief that cutting-edge science must translate into real-world impact, positioning Vertex as both a market leader and a driver of medical innovation.

 

Related: High-Paying Jobs in Healthcare Sector

 

6. Teresa Graham – CEO, Roche Pharmaceuticals

Teresa Graham is the Chief Executive Officer of Roche Pharmaceuticals, a division of the Swiss healthcare giant Roche, appointed in 2023. With a career spanning more than two decades in the pharmaceutical industry, Graham has extensive experience in global strategy, commercialization, and patient-focused innovation.

Before becoming CEO, she served as Head of Global Product Strategy at Roche, where she played a key role in shaping the company’s oncology portfolio and guiding strategic investments in immunology and rare diseases. Known for her strong business acumen and patient-first philosophy, Graham has been instrumental in driving Roche’s transformation toward personalized healthcare, harnessing data, diagnostics, and targeted therapies to improve outcomes.

As CEO, she leads one of the world’s largest pharmaceutical businesses, overseeing a robust pipeline that spans oncology, neuroscience, immunology, and infectious diseases. She has emphasized sustainability, equitable access to medicines, and the integration of digital technologies in drug development and delivery.

Graham is widely respected as a modern healthcare leader who blends strategic vision with operational excellence. Her leadership continues to advance Roche’s mission of delivering science-driven, innovative therapies to patients worldwide, while maintaining the company’s global leadership in pharmaceuticals.

 

7. Judy Faulkner – Founder & CEO, Epic Systems

Judy Faulkner is the founder and Chief Executive Officer of Epic Systems, one of the world’s largest healthcare software companies. She started Epic in 1979 in Madison, Wisconsin, with just a few employees and a vision to transform healthcare through data-driven solutions. Today, Epic is a global leader in electronic health records (EHRs), serving more than 300 million patients worldwide.

Faulkner is known for her unique leadership style, focusing on long-term vision rather than quarterly results. Epic remains privately held, which allows it to prioritize innovation and client partnerships over short-term shareholder pressure. Under her guidance, the company has developed advanced EHR systems, patient portals like MyChart, and interoperability tools that have become critical to modern healthcare delivery.

Recognized as one of the most influential figures in healthcare IT, Faulkner has received numerous accolades for her contributions to digital health. Beyond business, she has pledged to give away 99% of her wealth to philanthropic causes. Her legacy lies not only in shaping how hospitals and clinicians use technology but also in pushing the industry toward greater efficiency, patient empowerment, and data transparency.

 

8. Prof. Özlem Türeci – Co-founder & Chief Medical Officer, BioNTech

Prof. Özlem Türeci, M.D., is the Co-founder and Chief Medical Officer of BioNTech, the German biotechnology company best known for developing one of the world’s first mRNA-based COVID-19 vaccines with Pfizer. A physician-scientist and immunologist, Türeci has dedicated her career to advancing personalized medicine, immunotherapies, and cancer research.

Before BioNTech, she co-founded Ganymed Pharmaceuticals, focused on cancer antibody therapies, which was later acquired by Astellas. At BioNTech, founded in 2008 with her husband, Dr. Uğur Şahin, and colleagues, she has been instrumental in translating cutting-edge science into therapies for both oncology and infectious diseases. Her leadership and scientific expertise were pivotal in the rapid development of the COVID-19 vaccine, which has saved millions of lives worldwide.

Türeci continues to spearhead BioNTech’s pipeline, particularly in immuno-oncology, where the company is exploring mRNA-based cancer vaccines and novel immunotherapies. She is also a strong advocate for advancing women in STEM and serves as an inspirational figure globally for combining academic rigor with entrepreneurial impact.

Her legacy is defined by bridging science and patient need, and her work at BioNTech continues to shape the future of medicine far beyond the pandemic.

 

9. Seema Verma – EVP & GM, Oracle Health and Life Sciences

Seema Verma is the Executive Vice President and General Manager for Oracle Health and Life Sciences, where she leads strategy, innovation, and global operations across digital health and clinical data platforms. She is best known for her prior role as Administrator of the Centers for Medicare & Medicaid Services (CMS) from 2017 to 2021, where she oversaw healthcare coverage for over 140 million Americans and managed a budget exceeding $1 trillion.

At CMS, Verma spearheaded reforms to modernize Medicaid, drive value-based care, expand telehealth, and reduce regulatory burdens for providers. Her tenure was marked by a push to increase transparency in pricing, improve interoperability in health IT, and enhance consumer choice. After leaving public service, she joined Oracle, where she now focuses on scaling digital health technologies, leveraging data to improve care delivery, and advancing interoperability on a global level.

Verma is widely recognized for her thought leadership at the intersection of healthcare, technology, and policy. She has been a strong advocate for innovation-driven healthcare and continues to influence how technology companies collaborate with providers and governments to deliver patient-centered care.

 

10. Angela Hwang – CEO-Partner, Flagship Pioneering & CEO, Metaphore Biotechnologies

Angela Hwang is a global healthcare leader currently serving as CEO-Partner at Flagship Pioneering and CEO of its portfolio company, Metaphore Biotechnologies. She is widely known for her long career at Pfizer, where she most recently served as Chief Commercial Officer and President of the Pfizer Biopharmaceuticals Group. In this role, she oversaw a $40+ billion portfolio spanning vaccines, oncology, rare diseases, and internal medicine.

During her tenure at Pfizer, Hwang played a pivotal role in the global launch of the Pfizer-BioNTech COVID-19 vaccine, helping to distribute one of the most significant medical innovations of the century. She also drove Pfizer’s transformation into a more agile and patient-centric company, leading efforts to harness digital tools, real-world data, and global partnerships to deliver medicines faster and more effectively.

At Flagship Pioneering, Hwang continues to shape the biotech landscape by nurturing breakthrough science into scalable companies, with Metaphore Biotechnologies focusing on next-generation protein engineering. She is also a strong advocate for diversity and leadership development, mentoring women and underrepresented groups in STEM and business. Her career reflects a blend of commercial expertise, scientific vision, and purpose-driven leadership.

 

Related: Importance of Communication in Healthcare Management

 

11. Dr. Hanan H. Balkhy – WHO Regional Director for the Eastern Mediterranean

Dr. Hanan H. Balkhy is the World Health Organization’s Regional Director for the Eastern Mediterranean, appointed in 2023. A physician and global health leader from Saudi Arabia, she has dedicated her career to combating infectious diseases and advancing antimicrobial resistance (AMR) awareness. Before joining WHO in this leadership role, she served as the Assistant Director-General for AMR at WHO Headquarters, where she coordinated global strategies to tackle one of the most pressing health threats of our time.

Trained as a pediatrician and infectious disease specialist, Dr. Balkhy has held several academic and policy roles, including Executive Director for Infection Prevention and Control at Saudi Arabia’s Ministry of National Guard Health Affairs. She has published extensively on AMR and has been a key voice in shaping international guidelines on antimicrobial stewardship.

As Regional Director, she oversees WHO’s work in 22 countries, addressing complex health challenges such as fragile health systems, pandemic preparedness, and health equity. Her leadership is characterized by a collaborative approach, uniting governments, institutions, and civil society to strengthen healthcare delivery. Dr. Balkhy is widely respected for combining medical expertise with strategic diplomacy, ensuring that global health initiatives translate into tangible outcomes for vulnerable populations.

 

12. H.E. Dr. Hanan Mohamed Al Kuwari – Minister of Public Health, Qatar

Her Excellency Dr. Hanan Mohamed Al Kuwari is Qatar’s Minister of Public Health and Managing Director of Hamad Medical Corporation (HMC), the country’s largest healthcare provider. Appointed as Minister in 2016, she has been central to transforming Qatar’s healthcare system into one of the most advanced and patient-centered in the region.

Dr. Al Kuwari began her career as a healthcare researcher before joining HMC, where she rose through leadership roles to oversee the corporation’s network of hospitals, specialized care centers, and emergency services. Under her guidance, Qatar has made significant strides in expanding universal health coverage, modernizing hospital infrastructure, and investing heavily in preventive and digital healthcare solutions.

Internationally, she has represented Qatar at the World Health Assembly and other global health forums, where she advocates for sustainable healthcare development, public health preparedness, and innovation in service delivery. During the COVID-19 pandemic, she played a pivotal role in orchestrating Qatar’s public health response, balancing crisis management with continuity of care.

Dr. Al Kuwari’s leadership reflects a commitment to building resilient health systems, advancing research and education, and fostering global partnerships. Her influence extends beyond Qatar, contributing to shaping the future of healthcare in the wider Middle East.

 

13. Kiran Mazumdar-Shaw – Executive Chairperson, Biocon & Biocon Biologics

Kiran Mazumdar-Shaw is the Executive Chairperson of Biocon Limited and Biocon Biologics, India’s largest biopharmaceutical company and a global leader in affordable biologics. She founded Biocon in 1978 with a small investment, initially producing enzymes, and grew it into a multinational enterprise with a focus on diabetes, oncology, immunology, and biosimilars.

Often hailed as the “Biotech Queen of India,” Mazumdar-Shaw has been instrumental in making advanced therapies accessible and affordable, particularly in developing countries. Under her leadership, Biocon pioneered the development of biosimilars for insulin and monoclonal antibodies, achieving approvals in regulated markets like the U.S. and Europe. She has championed innovation in research while also advocating for equitable healthcare access worldwide.

Mazumdar-Shaw is also a strong proponent of corporate social responsibility, supporting initiatives in education, healthcare, and public health through the Biocon Foundation. Recognized internationally, she has featured on Forbes’ lists of most powerful women and has received numerous honors for entrepreneurship and philanthropy. Her leadership exemplifies how science, business, and social responsibility can intersect to create lasting global impact.

 

14. Ameera Shah – Promoter & Managing Director, Metropolis Healthcare

Ameera Shah is the Promoter and Managing Director of Metropolis Healthcare, one of India’s leading diagnostic laboratory chains. She transformed the company from a single pathology lab founded by her father into a multinational diagnostics network with operations across India, Africa, and other emerging markets.

Since taking leadership in the early 2000s, Shah has focused on building trust in diagnostics by introducing standardized testing, global quality benchmarks, and patient-centric service models. Today, Metropolis is known for its advanced pathology services, innovation in preventive health testing, and adoption of digital technologies to expand accessibility.

Shah has been a strong advocate for healthcare entrepreneurship in India, often highlighting the importance of diagnostics in preventive and precision medicine. She has received recognition from Forbes and Fortune for her contributions to healthcare leadership and for being one of India’s prominent women entrepreneurs. Beyond business, she mentors young leaders and supports initiatives that encourage women in leadership.

Her vision is to position diagnostics not just as a medical support service but as a core pillar of healthcare delivery, ensuring timely, reliable, and affordable access to patients worldwide.

 

15. Dr. Preetha Reddy – Executive Vice Chairperson, Apollo Hospitals

Dr. Preetha Reddy is the Executive Vice Chairperson of Apollo Hospitals, India’s largest integrated healthcare group and a pioneer in private healthcare delivery. A second-generation leader of the Apollo legacy, she has been instrumental in shaping the group’s strategic vision, ensuring that Apollo continues to set global benchmarks in quality, technology adoption, and patient-centric care.

Trained as a clinician with a strong focus on management, Dr. Reddy has played a pivotal role in expanding Apollo’s footprint across hospitals, clinics, pharmacies, and insurance. She has championed initiatives to bring advanced healthcare to underserved populations, including telemedicine networks and rural health programs. She has also been actively involved in strengthening clinical governance, quality standards, and patient safety practices across Apollo’s institutions.

Beyond her corporate role, Dr. Reddy is deeply engaged in public health policy and has contributed to shaping India’s healthcare agenda through industry bodies like FICCI and CII. She is a strong advocate for expanding access to affordable healthcare, women’s leadership in medicine, and the integration of digital technologies into care delivery. Her leadership has helped Apollo Hospitals evolve into a trusted global healthcare brand serving millions of patients.

 

Related: How to Effectively Manage a Healthcare Team?

 

16. Dr. Sangita Reddy – Joint Managing Director, Apollo Hospitals

Dr. Sangita Reddy is the Joint Managing Director of Apollo Hospitals, where she leads operations, digital transformation, and international business development. Known for her forward-looking approach, she has been a driving force behind Apollo’s adoption of cutting-edge technologies, making the group a leader in digital health, telemedicine, and AI-driven healthcare solutions.

Her leadership has been critical in scaling Apollo’s reach beyond urban centers to rural and underserved communities. She spearheaded Apollo’s telemedicine initiative, which has become one of the largest virtual health networks in Asia, offering access to specialized care in remote regions. Dr. Reddy has also been a strong proponent of integrating AI, robotics, and big data analytics to improve diagnosis, treatment, and patient experience.

In addition to her role at Apollo, she is an influential voice in global healthcare policy, having served as President of the Federation of Indian Chambers of Commerce and Industry (FICCI). She advocates for universal health coverage, public-private partnerships, and digital health ecosystems to strengthen India’s healthcare delivery.

Dr. Reddy embodies Apollo’s mission of bringing accessible, world-class care to millions, and her efforts in innovation and policy continue to shape the future of healthcare both in India and globally.

 

17. Zhong Huijuan – Chair & CEO, Hansoh Pharmaceutical Group

Zhong Huijuan is the founder, Chair, and Chief Executive Officer of Hansoh Pharmaceutical Group, one of China’s largest and most innovative drug companies. A former chemistry teacher, she established the company in 1995 in Lianyungang, China, with a focus on generic medicines. Over the years, she transformed Hansoh into a biopharmaceutical leader with a strong pipeline in oncology, central nervous system disorders, infectious diseases, and diabetes.

Under her leadership, Hansoh became a publicly listed company on the Hong Kong Stock Exchange in 2019, cementing its position as a major player in Asia’s healthcare market. Zhong is recognized as one of the wealthiest self-made women in the world, but her reputation is equally tied to her relentless drive for innovation in medicine and accessibility. She has emphasized R&D investments to shift Hansoh from generics into cutting-edge therapeutics, especially cancer treatments that address urgent patient needs in China and beyond.

Zhong’s rise from educator to pharmaceutical leader embodies resilience, vision, and entrepreneurial excellence. She continues to shape China’s role in global biopharma, balancing commercial growth with a mission to improve healthcare outcomes for millions of patients.

 

18. Julie L. Gerberding – President & CEO, Foundation for the NIH

Dr. Julie L. Gerberding is the President and Chief Executive Officer of the Foundation for the National Institutes of Health (FNIH), a nonprofit that fosters public-private partnerships to advance biomedical research. Appointed in 2022, she leads efforts to accelerate discoveries in areas like cancer, neuroscience, infectious diseases, and global health.

A physician specializing in infectious diseases, Dr. Gerberding first rose to prominence as Director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009, where she guided the nation’s response to SARS, bioterrorism threats, and pandemic preparedness. She later served as Chief Patient Officer and Executive Vice President at Merck, focusing on patient engagement and global public health initiatives.

At FNIH, Gerberding leverages her expertise in science, policy, and industry to build collaborations between academia, government, and the private sector. Her leadership has strengthened initiatives such as the Accelerating Medicines Partnership and programs supporting vaccines, Alzheimer’s research, and precision medicine.

Widely respected as both a scientist and executive, Gerberding is a vocal advocate for health equity, global disease preparedness, and women in leadership. Her career reflects a lifelong mission to bridge science, policy, and innovation for the betterment of public health worldwide.

 

19. Nora D. Volkow – Director, National Institute on Drug Abuse (NIDA), NIH

Dr. Nora D. Volkow is the Director of the U.S. National Institute on Drug Abuse (NIDA) at the National Institutes of Health, a position she has held since 2003. A pioneering psychiatrist and neuroscientist, she is renowned for using brain imaging technologies such as PET scans to demonstrate how drug addiction affects brain function. Her research has been critical in reframing addiction as a brain disease rather than a moral failing, advancing treatment approaches rooted in science and compassion.

Under her leadership, NIDA has spearheaded major initiatives addressing the opioid epidemic, substance use disorders, and the intersection of mental health and addiction. She has also advocated for policies supporting evidence-based prevention, harm reduction, and expanded access to treatment. Volkow has been a key voice in integrating addiction science into broader public health policy, emphasizing the role of social determinants of health in substance use.

Her groundbreaking work has earned her international recognition as one of the world’s most influential neuroscientists. Beyond research, Volkow continues to be a public advocate, working to reduce stigma and expand resources for those affected by addiction. Her leadership bridges science, policy, and compassion to transform how society addresses substance use disorders.

 

20. Karen S. Lynch – Former CEO, CVS Health; Director, Thermo Fisher Scientific

Karen S. Lynch is the former President and Chief Executive Officer of CVS Health, one of the largest healthcare companies in the United States, serving over 100 million people through pharmacy services, insurance, and care delivery. Appointed CEO in 2021, she became the highest-ranking female executive in the Fortune 500 at the time.

During her tenure, Lynch led CVS Health through the challenges of the COVID-19 pandemic, overseeing the distribution of vaccines and the expansion of community-based health services. She played a central role in advancing CVS’s vision of becoming a diversified healthcare provider, integrating pharmacy, insurance (through Aetna), and primary care services under one umbrella. She also prioritized mental health initiatives and advanced the company’s commitments to health equity.

Before CVS, Lynch served as President of Aetna, where she focused on innovation in insurance and improving consumer experience. In 2024, she stepped down from CVS Health’s CEO role but continues to influence the healthcare industry as a Director at Thermo Fisher Scientific and other organizations.

Lynch is widely recognized as a trailblazer for women in corporate leadership and a strong advocate for reimagining healthcare delivery in ways that make care more accessible, affordable, and patient-centered.

 

Related: Top Healthcare Analytics Case Studies

 

Conclusion

The healthcare sector is in the midst of transformation, and these 20 women are at its helm, steering it with clarity and purpose. Their stories reveal a unifying theme: leadership grounded in innovation, inclusivity, and resilience can drive measurable impact across borders. From pioneering affordable biologics in emerging markets to championing digital health ecosystems, they are rewriting the rules of what it means to lead in a science-driven, patient-centered industry.

What makes their influence especially powerful is that it transcends titles and positions. These leaders are not only CEOs, ministers, or scientists—they are changemakers who view healthcare through a human lens. They remind us that advancing medicine is as much about compassion and equity as it is about cutting-edge research.

As the healthcare industry continues to evolve in the face of global challenges, their leadership will remain vital. They serve as role models for the next generation of innovators and decision-makers, particularly women aspiring to make their mark in science, policy, and entrepreneurship. Ultimately, this list is not just a celebration of their accomplishments—it is a recognition of their ongoing commitment to a healthier, more inclusive world.